- Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial
-
Kang K, Han S, Hong T, Jeon S, Paek J, Kang JH, Yim DS
- KMID: 2427152
- Yonsei Med J.
- 2016 Nov;57(6):1354-1360.
- doi: 10.3349/ymj.2016.57.6.1354
PURPOSE: A phase I clinical trial was conducted to evaluate the immunogenicity and safety of newly developed egg-cultivated trivalent inactivated split influenza vaccine (TIV) in Korea. MATERIALS AND METHODS: The TIV... -
- CITED
-
- Close
- SHARE
-
- Close
